NCT05446805 · RECRUITING

Depression and Driving

This study is examining how depression, early Alzheimer's-related brain changes, and antidepressant use affect how older adults drive. Researchers will use PET brain scans and spinal fluid tests to look for amyloid and tau proteins — the biological markers tied to Alzheimer's — and then measure real-world driving behavior. The phase is unspecified, meaning this is most likely an observational study, not a treatment trial.

You may qualify if

You're excluded if

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-06-08

View full record on ClinicalTrials.gov

All APOE4 clinical trials